These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 26482612
1. MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway. Du J, Wang L, Li C, Yang H, Li Y, Hu H, Li H, Zhang Z. Tumour Biol; 2016 Mar; 37(3):3939-47. PubMed ID: 26482612 [Abstract] [Full Text] [Related]
4. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. Wang YS, Wang YH, Xia HP, Zhou SW, Schmid-Bindert G, Zhou CC. Asian Pac J Cancer Prev; 2012 Mar; 13(1):255-60. PubMed ID: 22502680 [Abstract] [Full Text] [Related]
5. Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. She QB, Solit D, Basso A, Moasser MM. Clin Cancer Res; 2003 Oct 01; 9(12):4340-6. PubMed ID: 14555504 [Abstract] [Full Text] [Related]
6. Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog. Feng Y, Zhou S, Li G, Hu C, Zou W, Zhang H, Sun L. Arch Biochem Biophys; 2016 May 15; 598():57-65. PubMed ID: 27040383 [Abstract] [Full Text] [Related]
7. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K, Zhang T, Fan Y, Serick, Du G, Wu P, Geng D. Tumour Biol; 2016 Oct 15; 37(10):13469-13477. PubMed ID: 27465551 [Abstract] [Full Text] [Related]
8. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells. Du G, Cao D, Meng L. Mol Med Rep; 2017 May 15; 15(5):2713-2719. PubMed ID: 28447761 [Abstract] [Full Text] [Related]
9. miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1. Zhou G, Zhang F, Guo Y, Huang J, Xie Y, Yue S, Chen M, Jiang H, Li M. Biomed Pharmacother; 2017 Jan 15; 85():113-119. PubMed ID: 27930974 [Abstract] [Full Text] [Related]
10. Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway. Zheng J, Wu C, Xu Z, Xia P, Dong P, Chen B, Yu F. Mol Cell Biochem; 2015 Jan 15; 398(1-2):1-9. PubMed ID: 25148875 [Abstract] [Full Text] [Related]
11. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway. Xu H, Zhu J, Hu C, Song H, Li Y. J Physiol Biochem; 2016 Dec 15; 72(4):721-732. PubMed ID: 27534652 [Abstract] [Full Text] [Related]
12. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. Zhao G, Cai C, Yang T, Qiu X, Liao B, Li W, Ji Z, Zhao J, Zhao H, Guo M, Ma Q, Xiao C, Fan Q, Ma B. PLoS One; 2013 Dec 15; 8(1):e53906. PubMed ID: 23372675 [Abstract] [Full Text] [Related]
13. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway. Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH. Tumour Biol; 2016 Nov 15; 37(11):15315-15324. PubMed ID: 27699665 [Abstract] [Full Text] [Related]
14. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. Shang Y, Wang LQ, Guo QY, Shi TL. Int J Clin Exp Pathol; 2015 Nov 15; 8(3):2461-72. PubMed ID: 26045752 [Abstract] [Full Text] [Related]
15. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer. Sheng WZ, Chen YS, Tu CT, He J, Zhang B, Gao WD. World J Gastroenterol; 2016 Jun 28; 22(24):5532-9. PubMed ID: 27350731 [Abstract] [Full Text] [Related]